(Q26866479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Federico Perosa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Angelo Vacca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Vito Racanelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Patrizia Leone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Franco Dammacco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

1 reference

12 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

5 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

105

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

16

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

1172-1187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

The endosome-lysosome pathway and information generation in the immune system

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Protein degradation and protection against misfolded or damaged proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Cross-presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

NK cell MHC class I specific receptors (KIR): from biology to clinical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Assembly and export of MHC class I peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Recent advances in antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Antigen processing by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The seven dirty little secrets of major histocompatibility complex class I antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Functions of the proteasome: the lysis at the end of the tunnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The proteasome and MHC class I antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A gated channel into the proteasome core particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The 26S proteasome: a molecular machine designed for controlled proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Functional analysis of the proteasome regulatory particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The base of the proteasome regulatory particle exhibits chaperone-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

PA200, a nuclear proteasome activator involved in DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Structural basis for the activation of 20S proteasomes by 11S regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Ontogenesis of rat immune system: Proteasome expression in different cell populations of the developing thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Immunoproteasome expression in a nonimmune tissue, the ocular lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Mice completely lacking immunoproteasomes show major changes in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The final touches make perfect the peptide-MHC class I repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A giant protease with potential to substitute for some functions of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Production of an antigenic peptide by insulin-degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Cancer/testis (CT) antigens: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The carboxypeptidase ACE shapes the MHC class I peptide repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Use of chimeric proteins to investigate the role of transporter associated with antigen processing (TAP) structural domains in peptide binding and translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The ATP switch model for ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

ABC proteins in antigen translocation and viral inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Conformation of peptides bound to the transporter associated with antigen processing (TAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Translocation of long peptides by transporters associated with antigen processing (TAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Selectivity of MHC-encoded peptide transporters from human, mouse and rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Peptide size selection by the major histocompatibility complex-encoded peptide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Disulfide bond isomerization and the assembly of MHC class I-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Tapasin and other chaperones: models of the MHC class I loading complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

ER quality control: towards an understanding at the molecular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Optimization of the MHC class I peptide cargo is dependent on tapasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Expression of antigen processing and presenting molecules in brain metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Mutations in TAP genes are common in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Identification of E2F1 as an important transcription factor for the regulation of tapasin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Serum HLA class I antigens: markers and modulators of an immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

21 January 2018

Soluble HLA revisited

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

MHC antigens and tumor escape from immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5- versus type 12-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

The biochemistry and cell biology of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Bare lymphocyte syndrome: an opportunity to discover our immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

21 January 2018

TAP deficiency syndrome

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Processing and presentation of tumor antigens and vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT184

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJT184

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852952%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017